Browse Drug Recalls
528 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 528 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 528 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Dec 15, 2015 | Dextrose Injection,USP,70% 2000 mL VIAFLEX Plastic Container Bag, Pharmacy Bu... | Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in th... | Class I | Baxter Healthcare Corp. |
| Dec 15, 2015 | 0.9% Sodium Chloride Injection, USP, 250 mL VIAFLEX Plastic Container Bag, Rx... | Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in th... | Class I | Baxter Healthcare Corp. |
| Nov 4, 2015 | Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe f... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Nov 4, 2015 | Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal inje... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Nov 4, 2015 | Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Nov 4, 2015 | Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Oct 29, 2015 | HYDROCHLOROTHIAZIDE CAPSULES, USP, 12.5 mg, 10 cap/blister, 100-count carton,... | Presence of Particulate Matter | Class II | Amerisource Health Services |
| Oct 7, 2015 | HYDROCHLOROTHIAZIDE CAPSULES, USP, 12.5 mg, 3000 count bottles, Rx only, Manu... | Presence of Particulate Matter. | Class II | Vintage Pharmaceuticals LLC, DBA Qualitest Phar... |
| Aug 25, 2015 | 1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservati... | Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded i... | Class II | Hospira, Inc. |
| Aug 24, 2015 | Refresh P.M. (Mineral Oil 42.5% and White Petrolatum 57.3%) Lubricant Eye Oin... | Presence of Particulate Matter: Due to customer complaints of small black particles, identified a... | Class II | Allergan Sales, LLC |
| Aug 24, 2015 | BLEPHAMIDE (sulfacetamide sodium and prednisolone acetate ophthalmic ointment... | Presence of Particulate Matter: Due to customer complaints of small black particles, identified a... | Class II | Allergan Sales, LLC |
| Aug 24, 2015 | FML (fluorometholone ophthalmic ointment) 0.1%, 3.5 g tube, Rx only, Allergan... | Presence of Particulate Matter: Due to customer complaints of small black particles, identified a... | Class II | Allergan Sales, LLC |
| Aug 24, 2015 | Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant E... | Presence of Particulate Matter: Due to customer complaints of small black particles, identified a... | Class II | Allergan Sales, LLC |
| Jul 24, 2015 | ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x... | Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution | Class I | Teva Pharmaceuticals USA |
| Jul 17, 2015 | 0.9% Sodium Chloride Injection USP MINI-BAG Plus Container, 100 mL VIAFLEX Si... | Presence of Particulate Matter: Customer complaint for an insect found free floating inside a sin... | Class I | Baxter Healthcare Corp. |
| Jul 17, 2015 | 0.9% Sodium Chloride Injection USP, 50 mL Single Dose VIAFLEX Container bags,... | Presence of Particulate Matter: Customer complaint for an insect found free floating inside a sin... | Class I | Baxter Healthcare Corp. |
| Jul 2, 2015 | 0.9% Sodium Chloride Injection USP, 500 mL in VIAFLEX Plastic Container, Baxt... | Presence of Particulate Matter and Lack of Assurance of Sterility: The firm received a complaint ... | Class II | Baxter Healthcare Corp. |
| Apr 28, 2015 | Adrucil (fluorouracil injection, USP) Pharmacy Bulk Package Not for Direct In... | Presence of Particulate Matter: Black particulate matter was identified as aggregate of silicone ... | Class I | Teva Pharmaceuticals USA |
| Apr 23, 2015 | Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL... | Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles. | Class I | Hospira Inc. |
| Apr 23, 2015 | Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-... | Presence of Particulate Matter | Class I | Mylan Institutional LLC |
| Apr 13, 2015 | HEPARIN Sodium Injection USP 25,000 USP Units added to 250 mL 5% Dextrose Inj... | Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, ... | Class I | Pharmedium Services, LLC |
| Apr 13, 2015 | EPINEPHrine HCl 1 mg added to 250 mL 0.9% Sodium Chloride Injection USP (4 mc... | Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, ... | Class I | Pharmedium Services, LLC |
| Apr 13, 2015 | oxyTOCIN 15 Units added to 250 mL 5% Dextrose Injection USP, packaged in 250 ... | Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, ... | Class I | Pharmedium Services, LLC |
| Apr 13, 2015 | EPINEPHrine HCl 16 mg added to 250 mL 0.9% Sodium Chloride Injection USP (64 ... | Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, ... | Class I | Pharmedium Services, LLC |
| Apr 13, 2015 | EPINEPHrine HCl 4 mg added to 250 mL 0.9% Sodium Chloride Injection USP (16 m... | Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, ... | Class I | Pharmedium Services, LLC |
| Apr 13, 2015 | HEPARIN Sodium Injection USP, 12,500 USP Units added to 250 mL 5% Dextrose In... | Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, ... | Class I | Pharmedium Services, LLC |
| Mar 24, 2015 | 10% Dextrose Injection, USP, 250mL VIAFLEX Plastic bags, Manufactured by Bax... | Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal) | Class I | Baxter Healthcare Corp. |
| Mar 24, 2015 | Lactated Ringers Injection, USP, 250mL VIAFELX Plastic bags, Manufactured by ... | Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal) | Class I | Baxter Healthcare Corp. |
| Mar 24, 2015 | 5% Dextrose Injection, USP, 250mL VIAFLEX Plastic bags, Manufactured by Baxte... | Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal) | Class I | Baxter Healthcare Corp. |
| Mar 24, 2015 | 0.9% Sodium Chloride Injection, USP, in 250mL VIAFLEX Plastic bags, Manufactu... | Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal) | Class I | Baxter Healthcare Corp. |
| Mar 23, 2015 | Gemcitabine for Injection, USP, 1 g*/vial, Lyophilized powder in a Single-Use... | Presence of Particulate Matter | Class I | Mylan Institutional LLC |
| Mar 23, 2015 | Gemcitabine for Injection, USP, 200 mg*/vial, Lyophilized powder in a Single-... | Presence of Particulate Matter | Class I | Mylan Institutional LLC |
| Mar 23, 2015 | Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use... | Presence of Particulate Matter | Class I | Mylan Institutional LLC |
| Mar 18, 2015 | Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, pac... | Presence of Particulate Matter | Class I | Mylan Institutional LLC |
| Mar 18, 2015 | CARBOplatin Injection 450 mg/45 mL (10 mg/mL), 45 mL packaged in a 100 mL Mul... | Presence of Particulate Matter | Class I | Mylan Institutional LLC |
| Mar 11, 2015 | LACTATED RINGER'S IRRIGATION, USP, 3000 mL flexible container bag, Rx Only, M... | Non-Sterility: Confirmed customer report of dark, fibrous particulates floating within the soluti... | Class I | Hospira Inc. |
| Mar 5, 2015 | 0.9% Sodium Chloride Injection, USP, 250 mL, Rx only, VisIV Container, Hospi... | Presence of Particulate Matter: Confirmed finding of human hair floating in IV solution. | Class I | Hospira Inc. |
| Feb 24, 2015 | Droperidol injection, 2.5 mg/mL, 5 mg Total Dose, 2 mL Fill Volume per syring... | Presence of particulate. | Class II | SCA Pharmaceuticals |
| Feb 23, 2015 | PROMETHAZINE DM SYRUP (Promethazine Hydrochloride, USP and Dextromethorphan H... | Presence of Foriegn Substance: Plastic cap closure particulates may be present in the product. | Class II | Qualitest Pharmaceuticals |
| Jan 28, 2015 | Morphine Sulfate, 1 mg per mL (250 mg per 250 mL), 250 mL total volume in a 2... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | Bupivacaine HCl 0.0625%, 250 mL total volume in a 250 mL LifeCare Bag in Sodi... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | PHENYLephrine HCl, 40 mg added to 250 mL 0.9% Sodium Chloride Injection USP (... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | PHENYLephrine HCl, 10 mg added to 250 mL 0.9% Sodium Chloride Injection USP (... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | Fentanyl Citrate, 5 mcg per mL (1,250 mcg per 250 mL), 250 mL total volume in... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | PHENYLephrine HCl, 20 mg added to 250 mL 0.9% Sodium Chloride Injection USP (... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | PHENYLephrine HCl, 50 mg added to 250 mL 0.9% Sodium Chloride Injection USP (... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 28, 2015 | PHENYLephrine HCl, 60 mg added to 250 mL 0.9% Sodium Chloride Injection USP (... | Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride... | Class I | Pharmedium Services, LLC |
| Jan 21, 2015 | Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 3 mL bottle, Rx only, Distr... | Presence of Particulate Matter: lot is not meeting the specification limit for number of particle... | Class II | Sun Pharma Global Fze |
| Jan 20, 2015 | 0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Fore... | Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in... | Class I | Hospira Inc. |
| Dec 23, 2014 | Propofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single pati... | Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the n... | Class II | Hospira Inc. |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.